Apple looks to be making progress in its long-running effort to integrate blood glucose monitoring into the Apple Watch. According to Bloomberg sources, the company’s no-prick monitoring is currently at the “proof-of-concept stage” and is sufficiently effective that it might hit the market once it is scaled down.
It was originally tabletop-sized, but the technology, which utilises lasers to measure glucose content under the skin, has purportedly improved to the point where an iPhone-sized wearable prototype is in the works.
According to insiders, the system would not only assist those with diabetes in monitoring their illnesses, but it would also ideally warn others who are prediabetic. Afterwards, they could take action to stop Type 2 (adult-onset) diabetes.
Apple opted not to respond. It is said that the project has been under development for a while. In 2010, a sick Steve Jobs ordered his business to acquire the fledgling blood glucose monitoring company RareLight.
Following tweet of Bloomberg confirms the news.
BREAKING: Apple is making major progress on a no-prick blood glucose monitoring system for its smartwatch https://t.co/uyQoUjw6GV pic.twitter.com/MwqctxlsQ4
— Bloomberg (@business) February 22, 2023
According to reports, Apple managed the project under the guise of an unassuming company, Avolonte Health, but integrated it into the previously unidentified Exploratory Design Group (XDG). Among the top executives involved are CEO Tim Cook, Eugene Kim, the hardware lead for the Apple Watch, and others.
It Will Take Years Before Actual Product Will Be Available
Bloomberg estimates that it will be years before any actual product is available. Also, the industry has a poor history of successfully introducing no-prick monitors to the market.
In 2018, Verily, a health division of Alphabet, abandoned plans for a smart contact lens that would have monitored blood sugar levels through tears. In other words, even well-known companies with ample resources cannot guarantee success, and it is unclear how precise Apple’s answer would be.
There are compelling reasons to integrate this technology into wearables. Atrial fibrillation, low blood oxygen levels, and (as of Series 8) ovulation cycles can all be detected by the Apple Watch, which is widely touted as a health gadget.
Without the need for a skin-invasive device, such as a continuous glucose sensor that transmits data from a small needle equipped with electrodes to an external receiver, non-intrusive glucose monitoring could become a vital tool for people with diabetes. The Apple Watch may have an advantage over other smartwatches thanks to that simple strategy.
You can also go for:
- Several Of The Restrictions Microsoft Placed On Bing’s AI Chat Tools Are Already Being Lifted
- Microsoft And Nintendo Officially Announce Their 10-year Call Of Duty Agreement
Final Lines: Hope you got all the queries answered in this article. We appreciate your presence on our website. To follow our website click here americantechjournal.com.
